Skip to main content
Signal8

REGENXBIO Inc. (RGNX)

REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucopolysaccharidosis type II and type I, respectively; RGX-181, which is in preclinical development for late-infantile neuronal ceroid lipofuscinosis type II disease; RGX-202, undergoing Phase I/II evaluation for Duchenne muscular dystrophy; and RGX-381, at the preclinical stage for addressing the ocular manifestations of CLN2 disease. In addition to its internal programs, REGENXBIO Inc. licenses its NAV Technology Platform to other biotech and pharmaceutical enterprises. It also maintains a collaborative and licensing agreement with Neurimmune AG for the advancement of innovative gene therapies. Founded in 2008, REGENXBIO Inc. maintains its headquarters in Rockville, Maryland.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

REGENXBIO Inc. logo

REGENXBIO Inc.

NASDAQ:RGNXHealthcare
-2.83%$7.20
AH$7.20+0.00%vs close
Mkt Cap$475.29M
Float51.72M
O/S66.01M
Vol
$ Vol
RVOL
Inst Own63.7%
SI19.4%
Earnings
Dilution
Financials Summary
Revenue$170.44M
Net Income-$193.88M
Total Assets$453.03M
Free Cash Flow-$126.38M
Debt & Equity
Debt 72%
Equity 28%
Total Debt$260.52M
Total Equity$102.73M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in RGNX's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$453.03M
Liabilities$350.3M
Accounts Receivable$27.38M
Accounts Payable$21.36M
Inventory$0
PP&E (Net)$152.01M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue$170.44M$83.33M$90.24M$112.72M$470.35M$154.57M$35.23M$218.5M$10.39M$4.59M$7.59M$6.12M$6.09M
YoY Growth104.5%-7.7%-19.9%-76.0%204.3%338.7%-83.9%2002.4%126.5%-39.5%24.0%0.5%-
Cost of Revenue$20.3M$33.57M$37.21M$54.55M$51.83M$35.71M$8.24M$9.64M$1.71M$959K$1.5M$1.01M$324K
Gross Profit$150.14M$49.76M$53.03M$58.18M$418.51M$118.85M$26.99M$208.87M$8.68M$3.63M$6.08M$5.11M$5.76M
Gross Margin88.1%59.7%58.8%51.6%89.0%76.9%76.6%95.6%83.6%79.1%80.2%83.5%94.7%
Research and Development$228.3M$208.52M$232.27M$242.45M$181.44M$166.29M$124.19M$83.87M$57.22M$45.48M$17.28M$4.96M$5.05M
Selling, General, and Administrative$82.86M$76.62M$88.49M$85.28M$79.33M$63.82M$51.81M$36.85M$27.23M$23.59M$11.91M$3.85M$5.47M
Other$179K-$2.03M$397K-$6.68M-$2.24M$7.97M-$10K$42K$116K-$102K-$26K-$47K$0
Total Operating Expenses$311.34M$283.11M$321.16M$321.06M$258.53M$238.09M$175.99M$120.77M$84.57M$68.97M$29.16M$8.77M$10.53M
Operating Income (EBIT)-$161.2M-$233.35M-$268.13M-$262.88M$159.98M-$119.23M-$149M$88.1M-$75.89M-$65.34M-$23.14M-$3.68M-$4.78M
Operating Margin-94.6%-280.0%-297.1%-233.2%34.0%-77.1%-422.9%40.3%-730.2%-1423.8%-304.9%-60.2%-78.5%
Interest Expense$45.01M$12.66M$6.86M$23.25M$26.28M$771K$0$0$0$0$20K$321K$611K
Interest Income$12.27M$174K$25K$342K$719K$4.27M$2.95M$8.95M$0$0$0$0$0
Other Income (Expense)-$32.68M$6.24M$4.48M-$17.53M-$18.73M$13.22M$51.51M$16.02M$2.72M$1.94M$326K-$321K-$611K
Income Before Tax (EBT)-$193.88M-$227.1M-$263.65M-$280.4M$141.25M-$106.01M-$97.49M$104.12M-$73.17M-$63.4M-$22.81M-$4M-$5.39M
Income Tax Expense$0$0-$152K-$84K$13.41M$5.24M-$2.75M$4.18M$686K-$435K-$60K$0$0
Net Income-$193.88M-$227.1M-$263.49M-$280.32M$127.84M-$111.25M-$94.73M$99.94M-$73.17M-$62.97M-$22.81M-$4M-$5.39M
Net Income Margin-113.8%-272.5%-292.0%-248.7%27.2%-72.0%-268.9%45.7%-704.0%-1372.1%-300.6%-65.4%-88.5%
Supplementary Data
EPS-3.76-4.59-6.02-6.503.01-2.98-2.582.73-2.45-2.38-2.49-0.30-2.04
Diluted EPS-3.76-4.59-6.02-6.502.91-2.98-2.582.73-2.45-2.38-2.49-0.30-2.04
Weighted Average OS51.57M49.51M43.73M43.15M42.44M37.28M36.69M36.61M29.86M26.41M9.17M13.15M2.64M
EBITDA-$133.25M-$198.23M-$239.46M-$244.24M$177.09M-$96.83M-$90.34M$92.08M-$73.2M-$64.8M-$22.71M$0-$14K
EBITDA Margin-78.2%-237.9%-265.4%-216.7%37.7%-62.6%-256.4%42.1%-704.3%-1412.0%-299.3%--0.2%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Assets
Current Assets
Cash and Cash Equivalents$34.47M$57.53M$34.52M$96.95M$345.21M$338.43M$69.51M$75.56M$46.66M$24.84M$54.12M$1.12M$1.12M
Short-Term Investments$195.6M$177.16M$240.74M$267.69M$112.23M$137.31M$226.7M$244.2M$114.12M$64.71M$60.02M$0$0
Cash and Short-Term Investments$230.07M$234.69M$275.26M$364.64M$457.44M$475.74M$296.21M$319.76M$160.78M$89.55M$114.14M$1.12M$1.12M
Accounts Receivable$27.38M$21.57M$26.34M$30.29M$32.44M$43M$38.15M$8.59M$473K$1.03M$2.14M$1.88M$1.09M
Inventory$0$0$0$0$0$10.51M$0$5.73M$5.33M$1.77M$1.02M$0$0
Other Current Assets$11.9M$12.68M$18.85M$7.14M$10.2M$1.95M$4.2M$3.83M$1.41M$1.01M$851K$0$0
Total Current Assets$281.28M$278M$334.97M$415.98M$518.83M$531.2M$345.03M$337.91M$168M$93.37M$118.15M$3.03M$2.21M
Long-Term Assets
Property, Plant & Equipment Net$152.01M$171.31M$192.59M$206.8M$192.45M$120.28M$39.05M$28.7M$13.98M$9.32M$538K$0$0
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$15.13M$10.18M$38.87M$200.56M$391.91M$46.81M$103.78M$150.82M$15.62M$69.41M$102.53M$303K$303K
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$4.61M$6.5M$7.54M$9.93M$10.72M$9.88M$10.04M$26.38M$1.09M$625K$168K$157K$0
Total Long-Term Assets$171.75M$187.99M$239M$417.29M$595.08M$176.97M$152.88M$205.9M$30.68M$79.36M$103.23M$460K$303K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$453.03M$465.99M$573.97M$833.27M$1.11B$708.16M$497.91M$543.81M$198.68M$172.73M$221.38M$3.49M$2.51M
Liabilities
Current Liabilities
Accounts Payable$21.36M$22.8M$22.79M$27.21M$11.39M$10.62M$6.41M$4.41M$4.83M$1.54M$1.01M$334K$301K
Short-Term Debt$47.9M$0$0$0$0$0$0$0$0$0$0$3.83M$655K
Current Income Tax Payable$0$0$0$0$11.32M$3.13M$0$726K$0$0$0$0$0
Current Unearned Revenue$10.45M$115K$148K$1.83M$3.33M$449K$0$600K$0$0$127K$153K-$655K
Other Current Liabilities$20.97M$51.92M$86.04M$66.67M$57.74M$51.59M$10.9M$6.95M$3.82M$4.79M$1.83M$153K$0
Total Current Liabilities$118.09M$103.19M$130.27M$130.43M$130.47M$81.45M$33.68M$22.18M$14.44M$9.67M$4.34M$9.19M$4.65M
Long-Term Liabilities
Long-Term Debt$147.41M$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$18.94M$0$0$0$0$3.78M$3.33M$3.33M$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$1.1M$0$0$0$0$0
Other Long-Term Liabilities$638K$29.01M$49.73M$97.84M$134.21M$175.03M$1.83M$3.6M$1.21M$1.33M$233K$0$0
Total Long-Term Liabilities$232.2M$103.14M$131.96M$186.64M$219.13M$248.96M$14.04M$12.79M$1.21M$1.33M$233K$0$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$350.3M$206.34M$262.23M$317.07M$349.61M$330.41M$47.71M$34.97M$15.65M$10.99M$4.57M$9.19M$4.65M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$12.59M$11.78M
Common Stock$5K$5K$4K$4K$4K$4K$4K$4K$3K$3K$3K$0$10.88M
Retained Earnings-$1.13B-$932.15M-$705.05M-$441.55M-$161.23M-$289.07M-$177.82M-$83.02M-$187.76M-$114.59M-$51.62M-$28.81M-$24.81M
Comprehensive Income & Other-$687K-$741K-$4.43M-$15.4M-$2.57M-$360K$205K-$720K-$715K-$33K-$719K$0$0
Other Stockholders' Equity$1.23B$1.19B$1.02B$957.74M$925.53M$666.82M$628.01M$591.86M$370.78M$276.32M$268.43M$23.11M$11.78M
Total Equity$102.73M$259.65M$311.74M$516.2M$764.3M$377.75M$450.2M$508.85M$183.03M$161.74M$216.81M-$5.7M-$2.14M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$453.03M$465.99M$573.97M$833.27M$1.11B$708.16M$497.91M$543.81M$198.68M$172.73M$221.38M$3.49M$2.51M
Supplementary Data
Total Debt$260.52M$82.03M$89.29M$94.8M$86.68M$72.65M$11.29M$5.85M$0$0$0$2.4M$655K
Net Debt$226.05M$24.51M$54.77M-$2.15M-$258.53M-$265.77M-$58.22M-$69.71M-$46.66M-$24.84M-$54.12M$1.28M-$464K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Operating Activities
Net Income-$193.88M-$227.1M-$263.49M-$280.32M$127.84M-$111.25M-$94.73M$99.94M-$73.17M-$62.97M-$22.81M-$4M-$5.39M
Depreciation & Amortization$15.62M$16.21M$17.32M$12.91M$9.56M$8.41M$7.15M$3.98M$2.69M$544K$80K$3.68M$4.76M
Deferred Income Tax$0$0$0$0-$1.92M$3.84M-$38.97M$794K$1.34M$2M$322K$0$0
Stock-Based Compensation$34.56M$38.46M$40.27M$40.79M$38.81M$31.95M$26.85M$16.64M$10.61M$7.03M$2.92M$319K$0
Changes in Working Capital:
  Accounts Receivable-$7.66M$9.71M$3.94M$4.82M$14.12M-$9.9M-$8.62M-$16.8M$561K$1.07M-$1.34M-$799K-$36K
  Inventory$0$0$0$0$29.3M$17.85M$2.37M$5.35M-$2.2M$2.82M-$2.51M$1.72M$4.89M
  Accounts Payable-$2.28M-$292K-$2.79M$18.79M-$2.3M$3.87M$1.53M-$218K$2.62M$186K$590K$33K$257K
  Other Working Capital$21.73M-$3.88M-$12.03M-$9.63M-$899K$2.39M-$600K$3.9M-$86K$1.15M$220K$153K-$2.45M
Total Working Capital Change$11.78M$5.53M-$10.89M$13.98M$40.22M$14.22M-$5.33M-$7.77M$897K$5.23M-$3.04M$1.11M$2.66M
Other Non-Cash Items$7.96M-$6.23M-$1.61M$5.16M$4.36M-$1.23M-$2.68M-$8.93M-$347K-$399K$13K-$3.51M-$5.05M
Net Cash from Operating-$123.96M-$173.13M-$218.41M-$207.49M$218.88M-$54.06M-$107.7M$104.65M-$57.99M-$48.56M-$22.52M-$2.4M-$3.01M
Investing Activities
Capital Expenditures-$2.41M-$2.44M-$9.96M-$30.72M-$84.17M-$26.87M-$11.72M-$13.28M-$7.16M-$8.15M-$522K$0$0
Acquisitions$0$0$0$0-$4.99M-$149.63M-$295.98M-$179.71M-$479K$0$0$0$0
Purchases of Investments-$332.63M-$190.14M-$86.56M-$184.88M-$498.14M-$123.04M-$190.74M-$445.83M-$68.63M-$45.07M-$163.28M$0$0
Sales of Investments$319.11M$290.24M$287.47M$203.67M$175.68M$272.67M$296.01M$179.75M$71M$72.61M$0$0$0
Other Investing Activities$62K$5.78M$0$0$4.99M$149.63M$295.98M$179.71M$479K-$225K-$163.28M$0$0
Net Cash from Investing-$15.87M$103.45M$190.94M-$11.93M-$406.64M$122.76M$93.56M-$279.36M-$4.79M$19.16M-$163.8M$0$0
Financing Activities
Debt Repaid-------------
Common Stock Issuance$1.01M$131.07M$6.7M$1.74M$218.21M$1.8M$1.31M$190.56M$82.55M$119K$145.18M$0$0
Common Stock Repurchases$0$1.19M$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$115.76M-$39.58M-$41.67M-$30.58M-$22.96M$198.41M$7.06M$13.88M$2.05M$119K$107K$1K$0
Net Cash from Financing$116.77M$92.68M-$34.97M-$28.84M$195.25M$200.21M$8.38M$204.44M$84.6M$119K$239.31M$2.4M$1.97M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$23.06M$23M-$62.43M-$248.26M$7.48M$268.91M-$5.77M$29.73M$21.82M-$29.28M$52.99M$2K-$1.05M
Supplementary Data
Operating Cash Flow-$123.96M-$173.13M-$218.41M-$207.49M$218.88M-$54.06M-$107.7M$104.65M-$57.99M-$48.56M-$22.52M-$2.4M-$3.01M
Capital Expenditure-$2.41M-$2.44M-$9.96M-$30.72M-$84.17M-$26.87M-$11.72M-$13.28M-$7.16M-$8.15M-$522K$0$0
Free Cash Flow-$126.38M-$175.56M-$228.37M-$238.21M$134.7M-$80.93M-$119.42M$91.37M-$65.15M-$56.71M-$23.04M-$2.4M-$3.01M
Cash at Beginning$59.56M$36.55M$98.98M$347.24M$339.76M$70.84M$76.61M$46.88M$24.84M$54.12M$1.12M$1.12M$2.17M
Cash at End$36.5M$59.56M$36.55M$98.98M$347.24M$339.76M$70.84M$76.61M$46.66M$24.84M$54.12M$1.12M$1.12M